Literature DB >> 33394885

Intestinal Microbiome in Preterm Infants Influenced by Enteral Iron Dosing.

Thao Ho1,2, Anujit Sarkar2, Laura Szalacha2, Maureen W Groer2.   

Abstract

OBJECTIVES: The aim of the study was to compare the intestinal microbiome in very low birth weight (VLBW) infants who received different enteral iron supplementation (EIS) doses. STUDY
DESIGN: Longitudinal stool collection in 80 VLBW infants were conducted up to 2 months postnatally in a prospective study. The 16S rRNA regions V4 was used to calculate microbiome compositions and the Piphillin software was used for bacterial functional prediction. Linear mixed effect models and Wilcoxon rank-sum tests were performed to examine the relationships between initial EIS dosage and stool microbiome and bacterial functional potential.
RESULTS: There were 105 samples collected before and 237 collected after EIS started from infants with birth gestational age and weight of 28.1 ± 2.4 weeks and 1103 ± 210 g, respectively. The average postnatal age at start of EIS was 17.9 ± 6.9 days and the average initial EIS dose was 4.8 ± 1.1 mg · kg-1 · day-1. Infants who were started on ≥6 mg · kg-1 · day-1 had higher abundances of Proteus and Bifidobacterium and a lower alpha diversity than those started on lower doses (P < 0.05). Infants given higher EIS doses had higher bacterial predicted functional potentials for ferroptosis and epithelial invasion after 2 weeks post EIS.
CONCLUSIONS: Higher EIS dosage is linked to higher abundances of Proteus and Bifidobacterium, and a less diverse microbiome and higher predicted potential of bacterial epithelial invasion. These observational findings should be further studied in a randomized study to elucidate the optimal dosage of EIS in VLBW infants.
Copyright © 2020 by European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33394885      PMCID: PMC8138922          DOI: 10.1097/MPG.0000000000003033

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  42 in total

1.  Chronic use of oral iron supplements is associated with poor clinical outcomes in patients with gram-negative bacteremia.

Authors:  Alaa Atamna; Hani Hamud; Waseem Daud; Tzippy Shochat; Jihad Bishara; Avishay Elis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-01-26       Impact factor: 3.267

Review 2.  Anaemia of prematurity: pathophysiology and treatment.

Authors:  Ronald G Strauss
Journal:  Blood Rev       Date:  2010-11       Impact factor: 8.250

3.  The effects of iron fortification on the gut microbiota in African children: a randomized controlled trial in Cote d'Ivoire.

Authors:  Michael B Zimmermann; Christophe Chassard; Fabian Rohner; Eliézer K N'goran; Charlemagne Nindjin; Alexandra Dostal; Jürg Utzinger; Hala Ghattas; Christophe Lacroix; Richard F Hurrell
Journal:  Am J Clin Nutr       Date:  2010-10-20       Impact factor: 7.045

Review 4.  Nutritional iron turned inside out: intestinal stress from a gut microbial perspective.

Authors:  Guus A M Kortman; Manuela Raffatellu; Dorine W Swinkels; Harold Tjalsma
Journal:  FEMS Microbiol Rev       Date:  2014-09-29       Impact factor: 16.408

Review 5.  Antibiotics and the developing infant gut microbiota and resistome.

Authors:  Molly K Gibson; Terence S Crofts; Gautam Dantas
Journal:  Curr Opin Microbiol       Date:  2015-08-01       Impact factor: 7.934

6.  Iron therapy for preterm infants.

Authors:  Raghavendra Rao; Michael K Georgieff
Journal:  Clin Perinatol       Date:  2009-03       Impact factor: 3.430

7.  DADA2: High-resolution sample inference from Illumina amplicon data.

Authors:  Benjamin J Callahan; Paul J McMurdie; Michael J Rosen; Andrew W Han; Amy Jo A Johnson; Susan P Holmes
Journal:  Nat Methods       Date:  2016-05-23       Impact factor: 28.547

8.  Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms.

Authors:  J Gregory Caporaso; Christian L Lauber; William A Walters; Donna Berg-Lyons; James Huntley; Noah Fierer; Sarah M Owens; Jason Betley; Louise Fraser; Markus Bauer; Niall Gormley; Jack A Gilbert; Geoff Smith; Rob Knight
Journal:  ISME J       Date:  2012-03-08       Impact factor: 10.302

9.  Iron in Micronutrient Powder Promotes an Unfavorable Gut Microbiota in Kenyan Infants.

Authors:  Minghua Tang; Daniel N Frank; Audrey E Hendricks; Diana Ir; Fabian Esamai; Edward Liechty; K Michael Hambidge; Nancy F Krebs
Journal:  Nutrients       Date:  2017-07-19       Impact factor: 5.717

Review 10.  The Microbiota of the Extremely Preterm Infant.

Authors:  Mark A Underwood; Kristin Sohn
Journal:  Clin Perinatol       Date:  2017-03-22       Impact factor: 3.430

View more
  1 in total

Review 1.  Nutritional Supplements to Improve Outcomes in Preterm Neonates.

Authors:  Mohan Pammi; Ravi M Patel
Journal:  Clin Perinatol       Date:  2022-04-21       Impact factor: 2.642

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.